Discover undervalued stocks with Eulerpool.

Subscribe for $2

WuXi AppTec Co Stock 603259.SS

Price

109.03
Today +/-
+0
Today %
+0 %

WuXi AppTec Co stock price

Loading chart...
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the WuXi AppTec Co stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the WuXi AppTec Co stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the WuXi AppTec Co stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze WuXi AppTec Co's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

WuXi AppTec Co Stock Price History

DateWuXi AppTec Co Price
9/22/2025109.03 undefined
9/22/2025109.03 undefined
9/19/2025106.86 undefined
9/19/2025108.75 undefined
9/18/2025107.44 undefined
9/18/2025107.43 undefined
9/17/2025109.30 undefined
9/17/2025109.29 undefined
9/16/2025107.05 undefined
9/16/2025107.05 undefined
9/15/2025107.02 undefined
9/15/2025107.00 undefined
9/12/2025105.45 undefined
9/12/2025105.47 undefined
9/11/2025104.65 undefined
9/10/2025107.24 undefined
9/10/2025107.23 undefined
9/9/2025106.39 undefined
9/9/2025106.37 undefined
9/8/2025110.75 undefined
9/8/2025110.60 undefined
9/5/2025107.40 undefined
9/5/2025107.40 undefined
9/4/2025101.92 undefined
9/4/2025101.94 undefined
9/3/2025110.49 undefined
9/3/2025110.88 undefined
9/2/2025112.00 undefined
9/2/2025112.00 undefined
9/1/2025111.58 undefined
9/1/2025111.58 undefined
8/29/2025103.43 undefined
8/29/2025103.30 undefined
8/28/202595.68 undefined
8/28/202595.69 undefined
8/27/202595.50 undefined
8/27/202595.40 undefined
8/26/202596.80 undefined
8/25/202599.97 undefined
8/25/202599.98 undefined

WuXi AppTec Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into WuXi AppTec Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by WuXi AppTec Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects WuXi AppTec Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of WuXi AppTec Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into WuXi AppTec Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing WuXi AppTec Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on WuXi AppTec Co’s growth potential.

WuXi AppTec Co Revenue, EBIT and net profit per share

DateWuXi AppTec Co RevenueWuXi AppTec Co EBITWuXi AppTec Co Net Income
2027e57.28 B undefined18.95 B undefined16.69 B undefined
2026e50.45 B undefined16.57 B undefined14.56 B undefined
2025e44.18 B undefined15.15 B undefined13.97 B undefined
202439.24 B undefined11.14 B undefined9.45 B undefined
202340.34 B undefined11.42 B undefined9.61 B undefined
202239.35 B undefined9.54 B undefined8.81 B undefined
202122.9 B undefined4.59 B undefined5.1 B undefined
202016.54 B undefined3.3 B undefined2.96 B undefined
201912.87 B undefined2.57 B undefined1.86 B undefined
20189.61 B undefined1.95 B undefined2.26 B undefined
20177.77 B undefined1.74 B undefined1.23 B undefined
20166.12 B undefined1.23 B undefined975 M undefined
20154.88 B undefined475 M undefined349 M undefined

WuXi AppTec Co Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (B)
NET INCOME (B)
NET INCOME GROWTH (%)
DIV. ()
DIV. GROWTH (%)
SHARES (B)
DOCUMENTS
20152016201720182019202020212022202320242025e2026e2027e
4.886.127.779.6112.8716.5422.939.3540.3439.2444.1850.4557.28
-25.2526.9623.8133.8928.4638.5171.842.51-2.7212.5914.1813.55
34.2840.4741.4939.1338.9437.8836.1437.1941.0941.3136.6932.1428.30
1.672.483.223.765.016.268.2814.6416.5816.21000
0.350.981.232.261.862.965.18.819.619.4513.9714.5616.69
-179.3725.8584.27-17.9659.5772.2072.919.00-1.6247.814.2514.63
----0.250.400.300.520.890.990.980.921.05
0000060-2573.3371.1511.24-1.01-6.1214.13
2.112.122.212.412.782.842.913.132.972.88000
- - - - - - - - - - - - -
Details

Keystats

ⓘ

Revenue and Growth

The WuXi AppTec Co Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the WuXi AppTec Co is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETS
CASH BALANCE (B)
RECEIVABLES (B)
OTHER REC. (B)
INVENTORIES (B)
OTHER CURRENT LIAB. (B)
CURRENT ASSETS (B)
TANGIBLE ASSETS (B)
LONG-T. INVEST. (B)
LONG-T. REC. (M)
INTANGIBLE ASSETS (B)
GOODWILL (B)
OTHER NON-CURRENT ASSETS (B)
NON-CURRENT ASSETS (B)
TOTAL ASSETS (B)
LIABILITIES
COMMON STOCK (B)
ADDITIONAL PAID-IN CAPITAL (B)
RETAINED EARNINGS (B)
OTHER EQUITY (M)
UNREAL. GAINS/LOSSES (M)
EQUITY (B)
LIABILITIES (B)
PROVISIONS (B)
OTHER SHORT-TERM LIAB. (B)
SHORT-TERM DEBTS (B)
LONG-TERM DEBT PORTION (M)
SHORT-TERM REC. (B)
LONG-T. LIAB. (B)
DEFERRED TAXES (M)
OTHER LIAB. (B)
LONG-T. LIABILITIES (B)
DEBT (B)
TOTAL CAPITAL (B)
2015201620172018201920202021202220232024
                   
2.073.952.797.926.9715.428.77.9914.5620.27
1.461.371.62.383.324.215.397.029.148.94
2.430.070.030.090.060.041.251.421.281.52
0.250.510.730.951.742.695.915.674.745.4
0.140.140.330.460.580.710.741.910.712.56
6.366.045.4711.8112.6623.0621.992430.4238.69
2.272.683.685.027.9310.3216.1323.826.5826.71
0.320.851.072.744.87.489.3910.1610.8411.27
0330000325.1771.3600
0.260.310.430.630.9211.61.781.861.57
0.310.330.961.141.361.391.931.821.820.97
0.170.350.991.341.573.044.13.132.141.11
3.334.557.1110.8616.5823.2333.4740.7643.2541.64
9.6910.5912.5822.6729.2446.2955.4564.7673.6780.33
                   
0.160.940.941.171.652.442.962.962.972.89
1.543.493.0311.9810.2922.6825.7326.5128.424.34
1.641.012.244.785.928.3312.5319.8426.833.37
3212913856156237-271.4224112.31300.89
0000000000
3.375.576.3417.9718.0233.6840.9549.3458.2860.89
0.260.310.330.380.570.931.931.641.651.75
0.240.80.520.841.131.532.162.873.193.14
2.312.62.452.412.964.046.425.895.966.33
0.180.491.320.141.621.242.263.893.674.75
0000348177220.18205.34295.04260.1
2.994.24.623.766.637.9212.9814.514.7616.23
000.30.023.742.891.631.761.793.51
3563103112231283324.13440.46530.11522.41
0.230.260.820.611.222.481.441.061.080.99
0.260.331.220.745.25.653.393.263.45.01
3.264.535.844.511.8313.5716.3717.7618.1521.24
6.6210.112.1822.4829.8547.2657.3267.176.4382.13
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of WuXi AppTec Co provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand WuXi AppTec Co's financial health and stability.

Assets

WuXi AppTec Co's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that WuXi AppTec Co must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of WuXi AppTec Co after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into WuXi AppTec Co's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B)
DEPRECIATION (B)
DEFERRED TAXES (M)
CHANGES IN WORKING CAPITAL (M)
NON-CASH ITEM (M)
PAID INTEREST (M)
PAID TAXES (M)
NET CASH FLOW FROM OPERATING ACTIVITIES (B)
CAPITAL EXPENDITURES (M)
CASH FLOW FROM INVESTING ACTIVITIES (M)
CASH FLOW FROM OTHER INVESTING ACTIVITIES (B)
INTEREST INCOME AND EXPENSES (M)
NET DEBT CHANGE (B)
NET CHANGE IN EQUITY (M)
CASH FLOW FROM FINANCING ACTIVITIES (B)
CASH FLOW FROM OTHER FINANCING ACTIVITIES (B)
TOTAL DIVIDENDS PAID (M)
NET CHANGE IN CASH FLOW (B)
FREE CASH FLOW (M)
SHARE-BASED COMPENSATION (M)
20152016201720182019202020212022
0000005.18.81
0000001.41.64
000000-5744
-1,656-2,012-2,641-3,580-4,828-5,892-8,043-10,978
000000-1,336-720
00000000
-80-193-201-190-122-47-165-202
0.741.761.791.642.923.974.5910.62
-928-957-1,363-2,248-2,531-3,031-6,936-9,965
-933-206-1,124-5,276-4,974-8,775-4,838-9,690
-00.750.24-3.03-2.44-5.742.10.28
00000000
-0.970.291.14-1.524.51-1.281.071.67
000000-1,570-810
0.39-0.17-0.716.981.569.89-1.72-1.28
1.36-0.46-1.858.59-2.2211.81-1.88-1.35
000-83-730-638-912-1,598
2.75.424.558.77.3314.9210.7521.6
-190.2799.1430.3-608.5384.2942.7-2,346.8650.34
00000000

WuXi AppTec Co stock margins

The WuXi AppTec Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of WuXi AppTec Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for WuXi AppTec Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the WuXi AppTec Co's sales revenue. A higher gross margin percentage indicates that the WuXi AppTec Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the WuXi AppTec Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the WuXi AppTec Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the WuXi AppTec Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the WuXi AppTec Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the WuXi AppTec Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

WuXi AppTec Co Margin History

WuXi AppTec Co Gross marginWuXi AppTec Co Profit marginWuXi AppTec Co EBIT marginWuXi AppTec Co Profit margin
2027e41.31 %33.08 %29.14 %
2026e41.31 %32.85 %28.87 %
2025e41.31 %34.3 %31.62 %
202441.31 %28.4 %24.08 %
202341.09 %28.32 %23.81 %
202237.19 %24.25 %22.4 %
202136.14 %20.03 %22.26 %
202037.88 %19.94 %17.9 %
201938.94 %19.97 %14.41 %
201839.13 %20.25 %23.52 %
201741.49 %22.46 %15.8 %
201640.47 %20.13 %15.94 %
201534.28 %9.73 %7.15 %

WuXi AppTec Co Stock Sales Revenue, EBIT, Earnings per Share

The WuXi AppTec Co earnings per share therefore indicates how much revenue WuXi AppTec Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue WuXi AppTec Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates WuXi AppTec Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of WuXi AppTec Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating WuXi AppTec Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

WuXi AppTec Co Revenue, EBIT and net profit per share

DateWuXi AppTec Co Sales per ShareWuXi AppTec Co EBIT per shareWuXi AppTec Co Earnings per Share
2027e19.88 undefined0 undefined5.79 undefined
2026e17.51 undefined0 undefined5.05 undefined
2025e15.33 undefined0 undefined4.85 undefined
202413.62 undefined3.87 undefined3.28 undefined
202313.61 undefined3.85 undefined3.24 undefined
202212.59 undefined3.05 undefined2.82 undefined
20217.86 undefined1.57 undefined1.75 undefined
20205.82 undefined1.16 undefined1.04 undefined
20194.63 undefined0.92 undefined0.67 undefined
20184 undefined0.81 undefined0.94 undefined
20173.52 undefined0.79 undefined0.56 undefined
20162.88 undefined0.58 undefined0.46 undefined
20152.32 undefined0.23 undefined0.17 undefined

WuXi AppTec Co business model

WuXi AppTec Co Ltd is a Chinese company that was founded in 2000 and specializes in the development of customer-oriented services in the pharmaceutical research and in vitro diagnostics sectors. The company operates multiple facilities in China, the USA, Europe, and Singapore. The business model of WuXi AppTec is based on the development and provision of services to meet the needs of customers worldwide. This includes activities such as bioanalysis, chemical development, drug manufacturing, and regulatory compliance and quality assurance services. In terms of various industries, the company is divided into three main divisions. The Chemical Division specializes in chemical development and drug manufacturing. The team has expertise in synthesizing complex molecules, scaling up for clinical trials, manufacturing bulk products for commercial use, and supplying APIs for formulation. The company has state-of-the-art facilities and technologies to ensure high product quality and fast production time. The Medical Device Division provides in vitro diagnostics for the global market to enable rapid and reliable medical diagnosis. The focus is on developing innovative technologies and applications in the fields of oncology, infectious diseases, and neurology. The company has many partnerships with leading in vitro diagnostics companies to enhance the quality and reach of products and services. The Biological Division specializes in the development of biopharmaceutical products and services. This includes the development of monoclonal antibodies to the production of recombinant proteins. The services include process development, manufacturing, characterization, and analysis of biological products. WuXi AppTec is at the forefront of technology and provides its customers with state-of-the-art facilities and technologies. In addition to the aforementioned services, WuXi AppTec also offers solutions in the field of bioanalytics, supporting the development of analytical methods and drug validation. The company has also recently expanded into other areas, including the acquisition of NextCODE Health, a firm specializing in genetic diagnostics and analysis tools. The company operates internationally and collaborates with a wide range of customers in the pharmaceutical and biotech sectors. It is also part of a global network of companies focusing on therapeutic technologies, clinical trials, drug marketing, and other aspects of the pharmaceutical industry. WuXi AppTec aims to provide its customers with high-quality products and services that are scientifically sound and effective. The company invests in research and development to provide its customers with the latest technologies and discoveries. WuXi AppTec Co is one of the most popular companies on Eulerpool.com.

WuXi AppTec Co SWOT Analysis

Strengths

WuXi AppTec Co Ltd possesses several notable strengths that contribute to its success in the market. Firstly, the company has a strong presence in the global pharmaceutical and biotechnology industry, allowing it to leverage its vast network and expand its customer base. Additionally, WuXi AppTec has a reputation for providing high-quality contract research and manufacturing services, which has earned the trust of numerous clients.

Weaknesses

Despite its strengths, WuXi AppTec Co Ltd also faces a number of weaknesses that need to be addressed. One major weakness is its heavy reliance on key customers, which poses a potential risk if these clients were to significantly reduce or halt their business with the company. Furthermore, WuXi AppTec operates in a highly competitive and rapidly evolving industry, requiring constant innovation and adaptability to stay ahead.

Opportunities

There are several opportunities that WuXi AppTec Co Ltd can capitalize on to fuel its growth. Firstly, the increasing demand for outsourced R&D and manufacturing services presents a significant opportunity for the company to expand its market share. Additionally, the growing focus on personalized medicine and the development of targeted therapies create new avenues for WuXi AppTec to provide specialized services to pharmaceutical and biotech companies.

Threats

WuXi AppTec Co Ltd faces various threats that could potentially impact its operations and profitability. One significant threat is the emergence of regulatory changes and stricter compliance requirements, which could increase the company's costs and hinder its ability to deliver services efficiently. Moreover, the constant risk of intellectual property theft and competition from both domestic and international players poses a challenge to maintaining market dominance.

Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

WuXi AppTec Co Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

WuXi AppTec Co historical P/E ratio, EBIT multiple, and P/S ratio

Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

WuXi AppTec Co shares outstanding

The number of shares was WuXi AppTec Co in 2024 — This indicates how many shares 2.881 B is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue WuXi AppTec Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates WuXi AppTec Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of WuXi AppTec Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating WuXi AppTec Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

WuXi AppTec Co stock splits

In WuXi AppTec Co's history, there have been no stock splits.

WuXi AppTec Co dividend history and estimates

In 2024, WuXi AppTec Co paid a dividend amounting to 0.99 undefined. Dividend means that WuXi AppTec Co distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for WuXi AppTec Co provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify WuXi AppTec Co’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating WuXi AppTec Co's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

WuXi AppTec Co Dividend History

DateWuXi AppTec Co Dividend
2027e1.05 undefined
2026e0.92 undefined
2020e0.2 undefined
20250.98 undefined
20240.99 undefined
20230.89 undefined
20220.52 undefined
20210.3 undefined
2020e0.2 undefined
20190.25 undefined

WuXi AppTec Co dividend payout ratio

In 2024, WuXi AppTec Co had a payout ratio of 17.98%. The payout ratio indicates the percentage of the company's profits that WuXi AppTec Co distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for WuXi AppTec Co represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for WuXi AppTec Co could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate WuXi AppTec Co's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

WuXi AppTec Co Payout Ratio History

DateWuXi AppTec Co Payout ratio
2027e18.12 %
2026e18.17 %
2025e18.21 %
202417.98 %
202318.31 %
202218.35 %
202117.29 %
202019.29 %
201936.81 %
201818.31 %
201718.31 %
201618.31 %
201518.31 %
Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for WuXi AppTec Co.

WuXi AppTec Co latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/20251.16 1.71  (47.22 %)2025 Q2
3/31/20250.72 1.28  (78.5 %)2025 Q1
12/31/20241.32 1.02  (-22.91 %)2024 Q4
9/30/20240.85 0.79  (-6.88 %)2024 Q3
6/30/20240.73 0.79  (7.85 %)2024 Q2
3/31/20240.7 0.66  (-5.98 %)2024 Q1
12/31/20230.69 0.49  (-29.18 %)2023 Q4
9/30/20230.76 0.94  (23.26 %)2023 Q3
6/30/20230.74 1.07  (44.15 %)2023 Q2
3/31/20230.76 0.72  (-4.95 %)2023 Q1
1
2
3

Eulerpool ESG Scorecard© for the WuXi AppTec Co stock

Eulerpool World ESG Rating (EESG©)

95/ 100

🌱 Environment

99

👫 Social

99

🏛️ Governance

86

Environment

Scope 1 - Direct Emissions
68,853.62
Scope 2 - Indirect emissions from purchased energy
467,798.35
Scope 3 - Indirect emissions within the value chain
143,722
Total CO₂ emissions
536,651.98
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees54.78
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

WuXi AppTec Co shareholders

%
Name
Stocks
Change
Date
4.96377 % G&C VI Limited143,015,79506/30/2025
3.63135 % G&C IV Hong Kong Limited104,626,05106/30/2025
3.02217 % Beijing Zhongmin Yinfu Investment Management Co., Ltd.87,074,56806/30/2025
2.53735 % G&C V Limited73,105,84306/30/2025
1.70061 % China Asset Management Co., Ltd.48,997,7883,219,5616/30/2025
1.59757 % Zhong Ou Asset Management Co., Ltd.46,029,135-75,4146/30/2025
1.58483 % China Merchants Fund Management Co. Ltd.45,662,03410,464,96412/31/2024
1.57197 % Hwabao WP Fund Management Co., Ltd.45,291,388-105,6003/31/2025
1.54686 % Huatai-PineBridge Fund Management Co., Ltd.44,568,027-67,1996/30/2025
1.42368 % E Fund Management Co. Ltd.41,019,093-3,289,2656/30/2025
1
2
3
4
5
...
10

WuXi AppTec Co Executives and Management Board

Dr. Ge Li

(56)
WuXi AppTec Co Chairman of the Board, President, Chief Executive Officer, Executive Director (since 2017)
Compensation 41.97 M

Dr. Minzhang Chen

(54)
WuXi AppTec Co Co-Chief Executive Officer, Executive Director (since 2020)
Compensation 10.93 M

Mr. Edward Hu

(61)
WuXi AppTec Co Vice Chairman of the Board, Global Chief Investment Officer, Executive Director (since 2017)
Compensation 8.37 M

Dr. Qing Yang

(55)
WuXi AppTec Co Co-Chief Executive Officer, Executive Director (since 2017)
Compensation 7.59 M

Mr. Zhaohui Zhang

(54)
WuXi AppTec Co Vice President, Executive Director, Chief Operating Officer of China Region (since 2017)
Compensation 7.05 M
1
2
3

WuXi AppTec Co Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
FibroGen Stock
FibroGen
SupplierCustomer0,800,750,460,390,27-0,49
Beijing Aosaikang Pharma A Stock
Beijing Aosaikang Pharma A
SupplierCustomer0,770,080,590,360,65
CStone Pharmaceuticals Stock
CStone Pharmaceuticals
SupplierCustomer0,640,540,100,590,72
Chengdu Kanghua Biological Products A Stock
Chengdu Kanghua Biological Products A
SupplierCustomer0,620,200,31-0,020,40
908 Devices Stock
908 Devices
SupplierCustomer0,460,460,610,780,83
Quanterix Stock
Quanterix
SupplierCustomer0,320,360,580,710,85
IDEAYA Biosciences Stock
IDEAYA Biosciences
SupplierCustomer0,160,110,250,780,800,80
Sensorion Stock
Sensorion
SupplierCustomer0,120,390,340,800,840,50
Fujian Foxit Software Development Joint Stock A Stock
Fujian Foxit Software Development Joint Stock A
SupplierCustomer-0,07-0,440,260,720,82
Harvard Bioscience Stock
Harvard Bioscience
SupplierCustomer-0,080,640,600,680,800,81
1
2
3

Most common questions regarding WuXi AppTec Co

What values and corporate philosophy does WuXi AppTec Co represent?

WuXi AppTec Co Ltd is a leading global pharmaceutical and biopharmaceutical open-access capability and technology platform company. It is committed to providing a broad portfolio of R&D and manufacturing services to help accelerate the discovery, development, and commercialization of innovative medicines. WuXi AppTec follows a corporate philosophy that emphasizes integrity, innovation, and collaboration. With a focus on quality and excellence, the company strives to create value for its customers, partners, and shareholders. WuXi AppTec Co Ltd's commitment to scientific expertise, customer-centricity, and continuous improvement reflects its dedication to advancing healthcare solutions and making a positive impact on society.

In which countries and regions is WuXi AppTec Co primarily present?

WuXi AppTec Co Ltd is primarily present in multiple countries and regions globally. Some of the key locations where the company has a significant presence include China, the United States, Germany, the United Kingdom, Japan, and Singapore. With a wide network of operations and collaborations, WuXi AppTec has established itself as a leading global pharmaceutical, biotechnology, and medical device company. Through its extensive presence and expertise, the company aims to provide innovative solutions and support to its clients in the healthcare industry across various markets.

What significant milestones has the company WuXi AppTec Co achieved?

WuXi AppTec Co Ltd, a leading global pharmaceutical company, has achieved several significant milestones. The company has established itself as a leader in providing comprehensive and integrated research and development services to enable the discovery and development of innovative drugs. WuXi AppTec has expanded its global footprint and now operates in over 30 countries. The company has also made progress in advancing precision medicine and has collaborated with industry leaders to accelerate drug development. WuXi AppTec's commitment to innovation and collaboration has contributed to its success in becoming a trusted partner for the biopharmaceutical industry.

What is the history and background of the company WuXi AppTec Co?

WuXi AppTec Co Ltd is a leading global pharmaceutical and biotechnology company. Founded in China in 2000, the company has grown to become a key player in the life sciences industry. WuXi AppTec provides a wide range of services to support drug research and development, including laboratory testing, manufacturing, and biologics services. With a focus on innovation and quality, the company has established strategic collaborations with numerous pharmaceutical companies and research institutions worldwide. WuXi AppTec has received multiple recognitions and awards for its contributions to the healthcare industry. Today, it continues to expand its global presence and drive advances in drug discovery and development.

Who are the main competitors of WuXi AppTec Co in the market?

The main competitors of WuXi AppTec Co Ltd in the market include Charles River Laboratories International Inc., Eurofins Scientific SE, LabCorp, and PPD Inc.

In which industries is WuXi AppTec Co primarily active?

WuXi AppTec Co Ltd is primarily active in the healthcare and pharmaceutical industries.

What is the business model of WuXi AppTec Co?

The business model of WuXi AppTec Co Ltd is focused on providing comprehensive R&D services and integrated platform solutions for the pharmaceutical, biotechnology, and medical device industries. With a customer-centric approach, WuXi AppTec offers a wide range of services, including discovery, development, and manufacturing of drugs and medical devices. By leveraging its expertise in research, development, and manufacturing, along with its global network of facilities and technologies, WuXi AppTec aims to enable its customers to accelerate the discovery and development of innovative therapies and improve the overall efficiency of the drug development process.

What is the P/E ratio of WuXi AppTec Co 2025?

The WuXi AppTec Co P/E ratio is 22.49.

What is the P/S ratio of WuXi AppTec Co 2025?

The WuXi AppTec Co P/S ratio is 7.11.

What is the Quality Investing of WuXi AppTec Co?

The Quality Investing for WuXi AppTec Co is 6/10.

What is the revenue of WuXi AppTec Co 2025?

The expected WuXi AppTec Co revenue is 44.18 B CNY.

How high is the profit of WuXi AppTec Co 2025?

The expected WuXi AppTec Co profit is 13.97 B CNY.

What is the business model of WuXi AppTec Co

WuXi AppTec Co Ltd is a global biotechnology and pharmaceutical company based in China. It was founded in 2000 and has built a wide portfolio of services in the areas of research and development, as well as manufacturing. The company is divided into various business divisions, including laboratory services, research and development, clinical trials, manufacturing and packaging, and services for biotech and pharmaceutical companies. It offers a range of services in laboratory services, such as chemical and biological analysis, preclinical safety and efficacy testing, as well as cellular and molecular biology. In the research and development area, the company works closely with its customers to develop new compounds and therapies. It also provides clinical trial services to test the effectiveness and safety of new drugs. Additionally, WuXi AppTec offers comprehensive manufacturing and packaging services and a range of consulting and support services. Overall, the company aims to support the research and development of new therapies and drugs, with a focus on quality and customer satisfaction.

What is the WuXi AppTec Co dividend?

WuXi AppTec Co pays a dividend of 0.52 CNY distributed over payouts per year.

How often does WuXi AppTec Co pay dividends?

The dividend cannot currently be calculated for WuXi AppTec Co or the company does not pay out a dividend.

What is the WuXi AppTec Co ISIN?

The ISIN of WuXi AppTec Co is CNE1000031K4.

What is the WuXi AppTec Co ticker?

The ticker of WuXi AppTec Co is 603259.SS.

How much dividend does WuXi AppTec Co pay?

Over the past 12 months, WuXi AppTec Co paid a dividend of 0.99 CNY . This corresponds to a dividend yield of about 0.91 %. For the coming 12 months, WuXi AppTec Co is expected to pay a dividend of 0.92 CNY.

What is the dividend yield of WuXi AppTec Co?

The current dividend yield of WuXi AppTec Co is 0.91 %.

When does WuXi AppTec Co pay dividends?

WuXi AppTec Co pays a quarterly dividend. This is distributed in the months of July, July, July, June.

How secure is the dividend of WuXi AppTec Co?

WuXi AppTec Co paid dividends every year for the past 9 years.

What is the dividend of WuXi AppTec Co?

For the upcoming 12 months, dividends amounting to 0.92 CNY are expected. This corresponds to a dividend yield of 0.84 %.

In which sector is WuXi AppTec Co located?

WuXi AppTec Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von WuXi AppTec Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of WuXi AppTec Co from 5/21/2025 amounting to 0.982 CNY, you needed to have the stock in your portfolio before the ex-date on 5/21/2025.

When did WuXi AppTec Co pay the last dividend?

The last dividend was paid out on 5/21/2025.

What was the dividend of WuXi AppTec Co in the year 2024?

In the year 2024, WuXi AppTec Co distributed 0.893 CNY as dividends.

In which currency does WuXi AppTec Co pay out the dividend?

The dividends of WuXi AppTec Co are distributed in CNY.

All fundamentals about WuXi AppTec Co

Our stock analysis for WuXi AppTec Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of WuXi AppTec Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.